Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toni L Pitcher

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
NPJ Parkinson'S Disease|July 21, 2017
Different PD-MCI criteria and risk of dementia in Parkinson's disease: 4-year longitudinal studyKyla-Louise Wood, Daniel J Myall, Leslie Livingston, et al.
Parkinsonism & Related Disorders|December 3, 2015
Metabolite ratios in the posterior cingulate cortex do not track cognitive decline in Parkinson's disease in a clinical settingMustafa Almuqbel, Tracy R Melzer, Daniel J Myall, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 20, 2020
Common Variants Coregulate Expression of GBA and Modifier Genes to Delay Parkinson's Disease OnsetWilliam Schierding, Sophie Farrow, Tayaza Fadason, et al.
Movement Disorders Clinical Practice|April 5, 2021
Neuropsychiatric Symptoms Are Associated with Dementia in Parkinson's Disease but Not Predictive of itKyla-Louise Horne, Michael R MacAskill, Daniel J Myall, et al.
Brain : a Journal of Neurology|February 12, 2011
Arterial spin labelling reveals an abnormal cerebral perfusion pattern in Parkinson's diseaseTracy R Melzer, Richard Watts, Michael R MacAskill, et al.
The New Zealand Medical Journal|July 9, 2021
Higher perceived stress and exacerbated motor symptoms in Parkinson's disease during the COVID-19 lockdown in New ZealandRebekah L Blakemore, Maddie J Pascoe, Kyla-Louise Horne, et al.
Biorxiv : the Preprint Server for Biology|June 5, 2026
Thalamic nuclei insights into Alzheimer's diseaseJulie P Vidal, Daniel J Myall, Jérémie Pariente, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|June 24, 2024
Early-phase amyloid PET reproduces metabolic signatures of cognitive decline in Parkinson's diseaseWilliam W T Aye, Megan R Stark, Kyla-Louise Horne, et al.
Frontiers in Neurology|May 21, 2019
Beta Amyloid Deposition Is Not Associated With Cognitive Impairment in Parkinson's DiseaseTracy R Melzer, Megan R Stark, Ross J Keenan, et al.
Journal of the Royal Society of New Zealand|October 23, 2024
The New Zealand Parkinson's progression programmeMichael R MacAskill, Toni L Pitcher, Tracy R Melzer, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
NPJ Parkinson'S Disease|July 21, 2017
Different PD-MCI criteria and risk of dementia in Parkinson's disease: 4-year longitudinal studyKyla-Louise Wood, Daniel J Myall, Leslie Livingston, et al.
Parkinsonism & Related Disorders|December 3, 2015
Metabolite ratios in the posterior cingulate cortex do not track cognitive decline in Parkinson's disease in a clinical settingMustafa Almuqbel, Tracy R Melzer, Daniel J Myall, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 20, 2020
Common Variants Coregulate Expression of GBA and Modifier Genes to Delay Parkinson's Disease OnsetWilliam Schierding, Sophie Farrow, Tayaza Fadason, et al.
Movement Disorders Clinical Practice|April 5, 2021
Neuropsychiatric Symptoms Are Associated with Dementia in Parkinson's Disease but Not Predictive of itKyla-Louise Horne, Michael R MacAskill, Daniel J Myall, et al.
Brain : a Journal of Neurology|February 12, 2011
Arterial spin labelling reveals an abnormal cerebral perfusion pattern in Parkinson's diseaseTracy R Melzer, Richard Watts, Michael R MacAskill, et al.
The New Zealand Medical Journal|July 9, 2021
Higher perceived stress and exacerbated motor symptoms in Parkinson's disease during the COVID-19 lockdown in New ZealandRebekah L Blakemore, Maddie J Pascoe, Kyla-Louise Horne, et al.
Biorxiv : the Preprint Server for Biology|June 5, 2026
Thalamic nuclei insights into Alzheimer's diseaseJulie P Vidal, Daniel J Myall, Jérémie Pariente, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|June 24, 2024
Early-phase amyloid PET reproduces metabolic signatures of cognitive decline in Parkinson's diseaseWilliam W T Aye, Megan R Stark, Kyla-Louise Horne, et al.
Frontiers in Neurology|May 21, 2019
Beta Amyloid Deposition Is Not Associated With Cognitive Impairment in Parkinson's DiseaseTracy R Melzer, Megan R Stark, Ross J Keenan, et al.
Journal of the Royal Society of New Zealand|October 23, 2024
The New Zealand Parkinson's progression programmeMichael R MacAskill, Toni L Pitcher, Tracy R Melzer, et al.
Pageof 3